THE TOP NEWS IN MARIJUANA LAW REFORM

Weekend Weed Read • September 07, 2024

Trump Criticizes Low-Level Marijuana Arrests, Predicts Passage of Amendment 3 Legalization Initiative

Republican presidential candidate Donald Trump declares that low-level marijuana arrests are a "waste [of] taxpayers' dollars," and predicts that Florida voters will approve legalization this November.

Nebraska: Voters To Decide on Medical Cannabis Access Measures

In Nebraska, a pair of citizen-initiated ballot measures regulating medical cannabis access to authorized patients qualify for the ballot.

Join NORML's Paul Armentano and JM Pedini for a special episode of Live with NORML for answers to your burning questions about the federal marijuana rescheduling process.

Clinical Trial: CBD Dosing Reduces Daytime Fatigue Compared to Placebo

Clinical trial data indicate CBD reduces daytime fatigue and improves psychological well-being.

Study: Endometriosis Patients Report Quality of Life Improvements Following Cannabis Use

Patients with endometriosis report using cannabis to effectively manage their pain or other related symptoms.

NORML Op-Ed: DEA’s Marijuana Hearing Is a Good Opportunity for Advocates To Make the Case for Rescheduling

The marijuana rescheduling hearing presents yet another opportunity for advocates to reinforce the case—previously and compellingly made by the Department of Health and Services—that cannabis does not meet the legal criteria of a Schedule I controlled substance.

Elections have consequences, and the outcomes will have major implications for the future of marijuana policy reform. NORML is working hard to ensure that voters are informed and engaged this November.

Please chip in $4.20 today to help us make America greener this Election Day.

NORML and The NORML Foundation
1420 K Street, NW, Suite 350
Washington, DC xxxxxx
(202) 483-5500 • [email protected]

Cannabis policy should be evidence-based.
Dispel marijuana myths with the NORML Fact Sheets.

Too many emails? Update your subscription preferences or unsubscribe at the link below.